Extremophile molds are invading art museums and devouring their collections. Stigma and climate change have fueled their ...

Modern smart collars have evolved from simple GPS trackers to sophisticated biometric instruments capable of early disease ...

MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, in Advanced NSCLC ...

AI is reshaping brand strategy. As agentic AI scales content marketing, brands must build entertainment fields, creating loyalty and gravity beyond transactions.

Last summer I polled the great art houses of Europe with a seemingly straightforward question: Had they had any recent experiences with mold in their collections? Mold is a perennial scourge in ...

It’s not so much the distance traveled, but what happens in between. In A Nutshell Analysis of runners’ online posts shows ...

The FDA has granted an in-person Type C meeting during the first quarter of 2026 New independent analyses across large observational ALS cohorts ...

The Independent Medical Alliance (IMA) today announced the release of Volume 2, Issue 1 of the Journal of Independent Medicine—the journal's fifth issue to date and the first issue of its second year ...

IMMUNOLIFE, a Phase 2 randomized exploratory study, will evaluate the potential of MaaT033 in combination with Cemiplimab versus Best Investigator Choice (i.e.: second line) in enhancing disease ...

Introduction Psychosocial safety climate (PSC) is increasingly recognised as an important organisational resource for promoting mental health at work and preventing psychosocial risks, which are ...